Julie Harker

829 total citations · 1 hit paper
8 papers, 629 citations indexed

About

Julie Harker is a scholar working on Pharmacology, Anesthesiology and Pain Medicine and Physiology. According to data from OpenAlex, Julie Harker has authored 8 papers receiving a total of 629 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Pharmacology, 3 papers in Anesthesiology and Pain Medicine and 3 papers in Physiology. Recurrent topics in Julie Harker's work include Pain Management and Opioid Use (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). Julie Harker is often cited by papers focused on Pain Management and Opioid Use (3 papers), Health Systems, Economic Evaluations, Quality of Life (3 papers) and Musculoskeletal pain and rehabilitation (3 papers). Julie Harker collaborates with scholars based in United Kingdom, Netherlands and Belgium. Julie Harker's co-authors include Jos Kleijnen, Geertruida E Bekkering, Małgorzata M Bała, Eliane Kellen, Kimberly J. Reid, Carla Truyers, Rob Riemsma, Kate Misso, Gill Worthy and Carol Forbes and has published in prestigious journals such as Clinical Therapeutics, Value in Health and Current Medical Research and Opinion.

In The Last Decade

Julie Harker

8 papers receiving 591 citations

Hit Papers

Epidemiology of chronic non-cancer pain in Europe: narrat... 2011 2026 2016 2021 2011 100 200 300

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Julie Harker United Kingdom 5 316 148 143 113 112 8 629
Andrew Nicolaou United Kingdom 10 351 1.1× 187 1.3× 152 1.1× 86 0.8× 110 1.0× 12 640
Niels Becker Denmark 5 364 1.2× 196 1.3× 105 0.7× 59 0.5× 145 1.3× 8 576
Liliane Mendonça Portugal 9 260 0.8× 113 0.8× 67 0.5× 69 0.6× 94 0.8× 22 434
Amol Deshpande Canada 11 517 1.6× 264 1.8× 190 1.3× 81 0.7× 57 0.5× 26 940
Eugenia Buta United States 16 214 0.7× 46 0.3× 167 1.2× 101 0.9× 76 0.7× 58 718
Jennifer Kerkvliet United States 10 193 0.6× 98 0.7× 138 1.0× 47 0.4× 98 0.9× 22 432
Richard L. Stieg United States 11 277 0.9× 270 1.8× 78 0.5× 50 0.4× 82 0.7× 19 626
Andreas Köpf Germany 16 138 0.4× 166 1.1× 130 0.9× 58 0.5× 55 0.5× 43 707
Sujata Thakurta United States 14 284 0.9× 39 0.3× 98 0.7× 69 0.6× 373 3.3× 70 936
Raheleh Khorsan United States 17 371 1.2× 30 0.2× 59 0.4× 125 1.1× 104 0.9× 36 897

Countries citing papers authored by Julie Harker

Since Specialization
Citations

This map shows the geographic impact of Julie Harker's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Julie Harker with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Julie Harker more than expected).

Fields of papers citing papers by Julie Harker

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Julie Harker. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Julie Harker. The network helps show where Julie Harker may publish in the future.

Co-authorship network of co-authors of Julie Harker

This figure shows the co-authorship network connecting the top 25 collaborators of Julie Harker. A scholar is included among the top collaborators of Julie Harker based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Julie Harker. Julie Harker is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

8 of 8 papers shown
1.
Forbes, Carol, Gillian Worthy, Julie Harker, et al.. (2014). Dose Efficiency of Erythropoiesis-Stimulating Agents for the Treatment of Patients With Chemotherapy-Induced Anemia: A Systematic Review. Clinical Therapeutics. 36(4). 594–610.e4. 14 indexed citations
2.
Riemsma, Rob, Nigel Armstrong, Antoinette D. I. van Asselt, et al.. (2012). Roflumilast for the management of severe chronic obstructive pulmonary disease : A Single Technology Appraisal. University of Groningen research database (University of Groningen / Centre for Information Technology). 1 indexed citations
3.
Harker, Julie & Jos Kleijnen. (2012). What is a rapid review? A methodological exploration of rapid reviews in Health Technology Assessments. International Journal of Evidence-Based Healthcare. 10(4). 397–410. 109 indexed citations
4.
Harker, Julie, Kimberly J. Reid, Geertruida E Bekkering, et al.. (2012). Epidemiology of Chronic Pain in Denmark and Sweden. Pain Research and Treatment. 2012. 1–30. 73 indexed citations
5.
Reid, Kimberly J., Julie Harker, Małgorzata M Bała, et al.. (2011). Epidemiology of chronic non-cancer pain in Europe: narrative review of prevalence, pain treatments and pain impact. Current Medical Research and Opinion. 27(2). 449–462. 362 indexed citations breakdown →
6.
Bała, Małgorzata M, Trudy Bekkering, Rob Riemsma, et al.. (2011). Epidemiology of chronic pain in the Netherlands. RePub (Erasmus University, Rotterdam). 2 indexed citations
7.
Riemsma, Rob, Carol Forbes, Julie Harker, et al.. (2011). PSY5 A Systematic Review of Tapentadol in Chronic Moderate to Severe Pain. Value in Health. 14(7). A411–A411. 1 indexed citations
8.
Riemsma, Rob, Carol Forbes, Julie Harker, et al.. (2011). Systematic review of tapentadol in chronic severe pain. Current Medical Research and Opinion. 27(10). 1907–1930. 67 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026